Robert L. Scavo - 20 Apr 2023 Form 3 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role: Chief Information Officer
Signature: /s/ Richard A. Cross, as Attorney-in-Fact, for Robert L. Scavo
Issuer symbol: ALHC
Transactions as of: 20 Apr 2023
Net transactions value: $0
Form type: 3
Filing time: 01 May 2023, 20:00:18 UTC
Next filing: 15 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ALHC	Common Stock						366,573	20 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALHC	Options (Right to Buy)							20 Apr 2023	Common Stock	325,833	$18.00	Direct	F2
holding	ALHC	Options (Right to Buy)							20 Apr 2023	Common Stock	36,496	$9.06	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (i) 81,504 shares of Common Stock of Alignment Healthcare, Inc. (the "Company"); (ii) 81,503 shares of unvested restricted stock, 50% of which vest on each of September 14, 2023 and September 14, 2024; (iii) 25,875 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company ("RSUs"), granted on March 25, 2021, 25% of which vested or will vest on the first four anniversaries of the grant date; (iv) 49,669 RSUs granted on March 8, 2022, 25% of which vested or will vest on the first four anniversaries of the grant date; and (v) 136,353 RSUs granted on September 12, 2022, 50% of which will vest on or about each of the third and fourth anniversaries of the grant date. An aggregate of 8,331 shares have been sold upon vesting of RSUs in non-discretionary sale-to-cover transactions. In each case, vesting is subject to the reporting person's continued service to the Company as of the applicable vesting date.
F2	Options vested or will vest 25% on each of the first four anniversaries of the March 25, 2021 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
F3	Options vested or will vest 25% on each of the first four anniversaries of the March 8, 2022 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.